US expert: Cancer treatment with ultrasound supported by Li Ka-shing attracts attention in Asia

Focused ultrasound, a non-invasive medical treatment backed by Hong Kong businessman Li Ka-shing, is considered a commercially attractive alternative to conventional treatments for many diseases, including cancer, according to one expert.

As the number of treatments and clinical trials has increased in recent years, developers of devices that produce high-intensity sound waves to target and destroy diseased tissues have attracted investment attention. Neal KassellFounder and president of the US-based Focused Ultrasound Foundation.

“The increase in the number of treatments, clinical trials, and research centers and the fact that equipment manufacturers are receiving investment from strategic investors and major financial institutions are indicators that focused ultrasound is increasing in scale,” said the former co-chair of neurosurgery. University of Virginia said.

He touched on US-based HistoSonics, a manufacturer of focused ultrasound devices that has attracted the attention of investors. Li Ka Shing Foundation donated A device made by HistoSonics at the University of Hong Kong to destroy liver tumors. The company, which completed a $102 million Series D financing round last month, counts a unit of healthcare giant Johnson & Johnson as one of its investors.

The Hong Kong billionaire’s charity announced last month that it would donate two more machines to hospitals in the city, sponsor the treatment of 20 patients and support the training of six doctors and radiologists by HistoSonics.